143 related articles for article (PubMed ID: 34689678)
1. Long-term effect of transtympanic intermittent pressure therapy using a tympanic membrane massage device for intractable meniere's disease and delayed endolymphatic hydrops.
Shojaku H; Takakura H; Asai M; Fujisaka M; Ueda N; Do TA; Tsubota M; Watanabe Y
Acta Otolaryngol; 2021 Nov; 141(11):977-983. PubMed ID: 34689678
[TBL] [Abstract][Full Text] [Related]
2. Effects of transtympanic intermittent pressure therapy using a new tympanic membrane massage device for intractable Meniere's disease and delayed endolymphatic hydrops: a prospective study.
Shojaku H; Aoki M; Takakura H; Fujisaka M; Asai M; Tsubota M; Ito Y; Watanabe Y
Acta Otolaryngol; 2021 Oct; 141(10):907-914. PubMed ID: 34520288
[TBL] [Abstract][Full Text] [Related]
3. Intermittent pressure therapy of intractable Meniere's disease and delayed endolymphatic hydrops using the transtympanic membrane massage device: a preliminary report.
Watanabe Y; Shojaku H; Junicho M; Asai M; Fujisaka M; Takakura H; Tsubota M; Yasumura S
Acta Otolaryngol; 2011 Nov; 131(11):1178-86. PubMed ID: 21838607
[TBL] [Abstract][Full Text] [Related]
4. Positive pressure therapy for Ménière's disease or syndrome.
van Sonsbeek S; Pullens B; van Benthem PP
Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD008419. PubMed ID: 25756795
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of the Meniett device in Ménière's disease: the Western Australian experience.
Rajan GP; Din S; Atlas MD
J Laryngol Otol; 2005 May; 119(5):391-5. PubMed ID: 15949105
[TBL] [Abstract][Full Text] [Related]
6. Clinical long-term effects of surgical treatment for intractable Meniere's disease: a more than 13-year follow-up after pressure treatment and further surgical treatment for intractable vertigo.
Liu F; Huang W; Chen K
Acta Otolaryngol; 2019 Dec; 139(12):1053-1057. PubMed ID: 31556757
[No Abstract] [Full Text] [Related]
7. Long-term effects of middle ear pressure therapy with the EFET01 device in patients with Ménière's disease and delayed endolymphatic hydrops in Japan.
Tram Anh D; Takakura H; Nakazato A; Morita Y; Shojaku H
Acta Otolaryngol; 2023 Oct; 143(10):840-844. PubMed ID: 37995205
[TBL] [Abstract][Full Text] [Related]
8. Long-term effects of the Meniett device in Japanese patients with Meniere's disease and delayed endolymphatic hydrops reported by the Middle Ear Pressure Treatment Research Group of Japan.
Shojaku H; Watanabe Y; Mineta H; Aoki M; Tsubota M; Watanabe K; Goto F; Shigeno K
Acta Otolaryngol; 2011 Mar; 131(3):277-83. PubMed ID: 21319947
[TBL] [Abstract][Full Text] [Related]
9. Efficiency of a novel middle ear pressure device for intractable definite Meniere's disease and delayed endolymphatic hydrops after certification by the public health insurance system in Japan.
Nakazato A; Takakura H; Do TA; Ueda N; Takeda N; Watanabe Y; Shojaku H
Acta Otolaryngol; 2022 May; 142(5):388-394. PubMed ID: 35544580
[TBL] [Abstract][Full Text] [Related]
10. Intermittent pressure therapy of intractable Ménière's disease using the Meniett device: a preliminary report.
Gates GA; Green JD
Laryngoscope; 2002 Aug; 112(8 Pt 1):1489-93. PubMed ID: 12172267
[TBL] [Abstract][Full Text] [Related]
11. Local overpressure treatment reduces vestibular symptoms in patients with Meniere's disease: a clinical, randomized, multicenter, double-blind, placebo-controlled study.
Thomsen J; Sass K; Odkvist L; Arlinger S
Otol Neurotol; 2005 Jan; 26(1):68-73. PubMed ID: 15699722
[TBL] [Abstract][Full Text] [Related]
12. Systematic review and meta-analysis of Meniett therapy for Meniere's disease.
Ahsan SF; Standring R; Wang Y
Laryngoscope; 2015 Jan; 125(1):203-8. PubMed ID: 24913022
[TBL] [Abstract][Full Text] [Related]
13. Meniett device in meniere disease: Randomized, double-blind, placebo-controlled multicenter trial.
Russo FY; Nguyen Y; De Seta D; Bouccara D; Sterkers O; Ferrary E; Bernardeschi D
Laryngoscope; 2017 Feb; 127(2):470-475. PubMed ID: 27515294
[TBL] [Abstract][Full Text] [Related]
14. Delayed Effect of Active Pressure Treatment on Endolymphatic Hydrops.
Covelli E; Volpini L; Atturo F; Benincasa AT; Filippi C; Tarentini S; Marrone V; Monini S; Vestri A; Barbara M
Audiol Neurootol; 2017; 22(1):24-29. PubMed ID: 28514787
[TBL] [Abstract][Full Text] [Related]
15. 12-month effect of middle ear pressure therapy with the EFET01 device for intractable definite Meniere's disease and delayed endolymphatic hydrops after certification by the public health insurance system in Japan.
Nakazato A; Takakura H; Ueda N; Do TA; Takeda N; Watanabe Y; Shojaku H
Acta Otolaryngol; 2022 Jun; 142(6):491-498. PubMed ID: 35723676
[TBL] [Abstract][Full Text] [Related]
16. Initial UK experience of patient satisfaction with the Meniett® device for Ménière's disease treatment.
Buchanan MA; Rai A; Prinsley PR
J Laryngol Otol; 2010 Oct; 124(10):1067-72. PubMed ID: 20537216
[TBL] [Abstract][Full Text] [Related]
17. The effects of transtympanic micropressure treatment in people with unilateral Meniere's disease.
Gates GA; Green JD; Tucci DL; Telian SA
Arch Otolaryngol Head Neck Surg; 2004 Jun; 130(6):718-25. PubMed ID: 15210552
[TBL] [Abstract][Full Text] [Related]
18. Positive pressure therapy for Meniere's syndrome/disease with a Meniett device: a systematic review of randomised controlled trials.
Syed MI; Rutka JA; Hendry J; Browning GG
Clin Otolaryngol; 2015 Jun; 40(3):197-207. PubMed ID: 25346252
[TBL] [Abstract][Full Text] [Related]
19. Meniett Therapy for Ménière's Disease: An Updated Meta-analysis.
Zhang SL; Leng Y; Liu B; Shi H; Lu M; Kong WJ
Otol Neurotol; 2016 Mar; 37(3):290-8. PubMed ID: 26808558
[TBL] [Abstract][Full Text] [Related]
20. The effect of the Meniett device in patients with Ménière's disease: long-term results.
Dornhoffer JL; King D
Otol Neurotol; 2008 Sep; 29(6):868-74. PubMed ID: 18617868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
